Autologous Adipose Tissue vs. Platelet-Rich Plasma for Treatment of Knee Osteoarthritis
Funding
Conflicts of Interest
References
- Gupta, A.; Maffulli, N. Allogenic umbilical cord tissue treatment of knee osteoarthritis. Sports Med. Arthrosc. Rev. 2022, 30, 162–165. [Google Scholar] [CrossRef] [PubMed]
- Harrison-Brown, M.; Scholes, C.; Hafsi, K.; Marenah, M.; Li, J.; Hassan, F.; Maffulli, N.; Murrell, W.D. Efficacy and safety of culture-expanded, mesenchymal stem/stromal cells for the treatment of knee osteoarthritis: A systematic review protocol. J. Orthop. Surg. Res. 2019, 14, 34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goldberg, A.; Mitchell, K.; Soans, J.; Kim, L.; Zaidi, R. The use of mesenchymal stem cells for cartilage repair and regeneration: A systematic review. J. Orthop. Surg. Res. 2017, 12, 39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sokolove, J.; Lepus, C.M. Role of inflammation in the pathogenesis of osteoarthritis: Latest findings and interpretations. Ther. Adv. Musculoskelet. Dis. 2013, 5, 77–94. [Google Scholar] [CrossRef] [PubMed]
- Little, C.B.; Hunter, D.J. Post-traumatic osteoarthritis: From mouse models to clinical trials. Nat. Rev. Rheumatol. 2013, 9, 485–497. [Google Scholar] [CrossRef] [PubMed]
- Loeser, R.F.; Goldring, S.R.; Scanzello, C.R.; Goldring, M.B. Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum. 2012, 64, 1697–1707. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bush, J.R.; Beier, F. TGF-β and osteoarthritis—The good and the bad. Nat. Med. 2013, 19, 667–669. [Google Scholar] [CrossRef] [PubMed]
- Aoki, C.A.; Borchers, A.T.; Li, M.; Flavell, R.A.; Bowlus, C.L.; Ansari, A.A.; Gershwin, M.E. Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun. Rev. 2005, 4, 450–459. [Google Scholar] [CrossRef] [PubMed]
- Bąkowski, P.; Kaszyński, J.; Wałecka, J.; Ciemniewska-Gorzela, K.; Bąkowska-Żywicka, K.; Piontek, T. Autologous adipose tissue injection versus platelet-rich plasma (PRP) injection in the treatment of knee osteoarthritis: A randomized, controlled study-study protocol. BMC Musculoskelet Disord. 2020, 21, 314. [Google Scholar] [CrossRef] [PubMed]
- Baria, M.; Pedroza, A.; Kaeding, C.; Durgam, S.; Duerr, R.; Flanigan, D.; Borchers, J.; Magnussen, R. Platelet-Rich Plasma Versus Microfragmented Adipose Tissue for Knee Osteoarthritis: A Randomized Controlled Trial. Orthop. J. Sports Med. 2022, 10, 23259671221120678. [Google Scholar] [CrossRef] [PubMed]
- Gobbi, A.; Dallo, I.; Rogers, C.; Striano, R.D.; Mautner, K.; Bowers, R.; Rozak, M.; Bilbool, N.; Murrell, W.D. Two-year clinical outcomes of autologous microfragmented adipose tissue in elderly patients with knee osteoarthritis: A multi-centric, international study. Int. Orthop. 2021, 45, 1179–1188. [Google Scholar] [CrossRef] [PubMed]
- Mautner, K.; Bowers, R.; Easley, K.; Fausel, Z.; Robinson, R. Functional outcomes following microfragmented adipose tissue versus bone marrow aspirate concentrate injections for symptomatic knee osteoarthritis. Stem Cells Transl. Med. 2019, 8, 1149–1156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Genechten, W.; Vuylsteke, K.; Martinez, P.R.; Swinnen, L.; Sas, K.; Verdonk, P. Autologous micro-fragmented adipose tissue (MFAT) to treat symptomatic knee osteoarthritis: Early outcomes of a consecutive case series. J. Clin. Med. 2021, 10, 2231. [Google Scholar] [CrossRef]
- Dallo, I.; Szwedowski, D.; Mobasheri, A.; Irlandini, E.; Gobbi, A. A prospective study comparing leukocyte-poor platelet-rich plasma combined with hyaluronic acid and autologous microfragmented adipose tissue in patients with early knee osteoarthritis. Stem Cells Dev. 2021, 30, 651–659. [Google Scholar] [CrossRef] [PubMed]
- Zaffagnini, S.; Andriolo, L.; Boffa, A.; Poggi, A.; Cenacchi, A.; Busacca, M.; Kon, E.; Filardo, G.; Martino, A.D. Microfragmented Adipose Tissue Versus Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Prospective Randomized Controlled Trial at 2-Year Follow-up. Am. J. Sports Med. 2022, 50, 2881–2892. [Google Scholar] [CrossRef] [PubMed]
Study Identifier | Study Phase; Estimated Enrollment (N) | Primary Outcome Measure(s) | Recruitment Status | Country |
---|---|---|---|---|
NCT04321629 | Phase II N = 60 |
| Recruiting | Poland |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gupta, A. Autologous Adipose Tissue vs. Platelet-Rich Plasma for Treatment of Knee Osteoarthritis. Biomedicines 2022, 10, 2527. https://doi.org/10.3390/biomedicines10102527
Gupta A. Autologous Adipose Tissue vs. Platelet-Rich Plasma for Treatment of Knee Osteoarthritis. Biomedicines. 2022; 10(10):2527. https://doi.org/10.3390/biomedicines10102527
Chicago/Turabian StyleGupta, Ashim. 2022. "Autologous Adipose Tissue vs. Platelet-Rich Plasma for Treatment of Knee Osteoarthritis" Biomedicines 10, no. 10: 2527. https://doi.org/10.3390/biomedicines10102527